SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-14-007919
Filing Date
2014-09-29
Accepted
2014-09-29 08:04:22
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-K a2221586z10-k.htm 10-K 887894
2 EX-31.1 a2221586zex-31_1.htm EX-31.1 7586
3 EX-31.2 a2221586zex-31_2.htm EX-31.2 7583
4 EX-32.1 a2221586zex-32_1.htm EX-32.1 4536
5 EX-32.2 a2221586zex-32_2.htm EX-32.2 4535
  Complete submission text file 0001047469-14-007919.txt   4449096

Data Files

Seq Description Document Type Size
6 EX-101.INS ctrv-20140630.xml EX-101.INS 381386
7 EX-101.SCH ctrv-20140630.xsd EX-101.SCH 38990
8 EX-101.CAL ctrv-20140630_cal.xml EX-101.CAL 26009
9 EX-101.DEF ctrv-20140630_def.xml EX-101.DEF 236701
10 EX-101.LAB ctrv-20140630_lab.xml EX-101.LAB 692926
11 EX-101.PRE ctrv-20140630_pre.xml EX-101.PRE 351557
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-55020 | Film No.: 141125455
SIC: 2834 Pharmaceutical Preparations